Tireogen and Endoluten as adjuncts in autoimmune thyroiditis
Comparison in people · 2017
- What was studied
- 218 adults aged 39–51: 89 standard treatment, 42 standard treatment plus Tireogen, 87 standard treatment plus Tireogen and Endoluten.
- Main finding
- At four months the author table reports TSH of 7.14 with standard care, 4.09 with adjunctive Tireogen, and 3.94 mIU/L with the combination. Antibody findings are reported with inconsistencies between table and narrative.
TSH at month four · Standard care 7.14 ± 0.86, Tireogen 4.09 ± 0.12, combination 3.94 ± 0.12 mIU/L. Shared baseline 8.84 ± 1.09. · The table marks both adjunctive arms as significantly different from standard care.
Reported findings and study design
89 patients received standard treatment, 42 added Tireogen and 87 added Tireogen plus Endoluten. The reported schedules were two Tireogen capsules daily and one Endoluten capsule every three days for four months. Capsule mass is unspecified. The levothyroxine unit in the reproduction is anomalous.
Population or model 218 adults aged 39–51: 89 standard treatment, 42 standard treatment plus Tireogen, 87 standard treatment plus Tireogen and Endoluten.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| TSH at month four | Standard care 7.14 ± 0.86, Tireogen 4.09 ± 0.12, combination 3.94 ± 0.12 mIU/L. Shared baseline 8.84 ± 1.09. | The table marks both adjunctive arms as significantly different from standard care. |
| Anti-thyroglobulin antibodies | 83.32 ± 3.28, 77.41 ± 1.18 and 18.91 ± 1.65 IU/L in the three groups, respectively. | The table marks both adjunctive arms. The narrative describes no antibody effect with Tireogen alone. |
| Anti-thyroid peroxidase antibodies | 361.24 ± 12.4, 357.23 ± 11.41 and 29.16 ± 2.54 IU/L, respectively. The table gives no significance mark for this row. |
The authors credit the St. Petersburg Institute of Bioregulation and Gerontology with developing both preparations. The study took place at the Centre for Revitalization and Health in Moscow. The design leaves allocation unspecified and the table gives one shared baseline.
Source for these results ↗ · Reviewed 2026-11-16
Study limitations and source details
Study limitations
- Allocation, masking and separate baseline values are unspecified. There was no Endoluten-only arm.
- The table marks an anti-thyroglobulin difference for Tireogen alone, while the narrative says Tireogen alone did not affect antibodies. The anti-TPO row gives no significance mark.
- The reproduction prints an anomalous levothyroxine unit. The exact background dose is uncertain.
Source details
Published conference abstract with author report
Published 2017 conference abstract and authors’ reproduced report, PDF pages 16–17. The 2015 and 2017 presentations describe the same study program.
Sources checked
Citation
D. A. Gorgiladze, R. N. Pinaev, V. A. Aleksandrov. Tireogen and Endoluten as adjuncts in autoimmune thyroiditis Innovation in Aging. 2017;1(Suppl 1):324. PMCID PMC6243877.
Related compounds
Tireogen
A peptide mixture extracted from young animal thyroid glands, described in a Russian report on thyroid hormones.
Endoluten
An animal pineal-gland peptide mixture used in the Gazprom occupational research program.